試す 金 - 無料
Covid-19 Testing Continues To Be A Pressing Issue
Bio Spectrum
|June 2020
One of the key constraints for Indian researchers and manufacturers to develop quickly testing kits in the country is dependency for raw materials such as enzymes, antigens, antibodies etc., required for research and manufacturing. All this is leading to delays in development of high quality and affordable testing solutions. Government should provide necessary support to develop the “ancillary” support for the researchers and manufacturers so that India can become self-reliant.
The World Health Organisation (WHO) has recommended that each country assess its risk and rapidly implement the necessary measures and prepare for a testing and clinical care surge to reduce COVID-19 transmission. Diagnostic testing will enable mitigation of COVID-19 virus spread and will facilitate achieving a level of preparedness and responsiveness to effectively identify, manage and care for new cases of COVID-19. The need for universal and massive testing across the population has, therefore, led to a race for technology innovations for COVID-19 diagnosis.
However, there have been several challenges with respect to the quality of certain types of tests and supply chain issues. Hopefully, as the days pass by, the situation could improve and stabilize.
Given that the virus is new, and the tests are still very new to the scene, it is important to note that the true clinical sensitivity is unknown. Therefore, the accuracy of results from the technologies that are available may not be of the desired levels. It is essential that aggressive research work is undertaken to enable the development of more accurate and reliable technologies.
As most of us are aware, by now, RT-PCR technology detects the virus while it is circulating in the body and enables diagnosis of the disease for appropriate treatment. RT-PCR test aids the identification of individuals who are infected, the management of patients, and implementation of mitigation strategies for preventing the spread of the disease.
このストーリーは、Bio Spectrum の June 2020 版からのものです。
Magzter GOLD を購読すると、厳選された何千ものプレミアム記事や、10,000 以上の雑誌や新聞にアクセスできます。
すでに購読者ですか? サインイン
Bio Spectrum からのその他のストーリー
Bio Spectrum
S&T Minister inaugurates Biotechnology Research and Innovation Council (BRIC) Secretariat
The Union Minister of (Independent State Charge) for Science and Technology (S&T) Dr Jitendra Singh recently inaugurated the Biotechnology Research and Innovation Council (BRIC) Secretariat by unveiling the inaugural curtain, marking the official opening of a new milestone in India's biotechnology journey.
1 min
February 2026
Bio Spectrum
US announces $50 B in awards to strengthen rural healthcare
The Centers for Medicare & Medicaid Services (CMS) has announced that all 50 states will receive awards under the Rural Health Transformation Program, a $50 billion initiative established under President Trump's Working Families Tax Cuts legislation (Public Law 119-21) to strengthen and modernise healthcare in rural communities across the country.
1 min
February 2026
Bio Spectrum
WHO unveils Traditional Medicine Global Library
At the second WHO Global Summit on Traditional Medicine, jointly organised with the Government of India, concluding recently in New Delhi, WHO unveiled the Traditional Medicine (TM) Global Library (GL), a first-of-its-kind digital platform consolidating 1.6 million resources on TM, from scientific studies to indigenous knowledge.
1 min
February 2026
Bio Spectrum
Telangana sets global ambition with Life Sciences Policy 2026-30 targeting $25 B investments
The Government of Telangana unveiled its Next-Gen Life Sciences Policy 2026-30 at the World Economic Forum Annual Meeting in Davos, signalling the State's intent to play a far more consequential role in shaping the future of global healthcare, advanced therapeutics, and sustainable bio-manufacturing.
1 min
February 2026
Bio Spectrum
WHO reveals major equity gaps in human genomics research
The World Health Organization (WHO) has published a new global analysis of human genomics in clinical research, covering more than three decades of studies registered between 1990 and 2024.
1 min
February 2026
Bio Spectrum
Biotium launches GlycoLiner Cell Surface Glycoprotein Labeling Kits
US-based Biotium, a leading innovator in fluorescent dyes and life science reagents, has announced the launch of GlycoLiner Cell Surface Glycoprotein Labeling Kits for rapid, selective, and covalent labeling of cell surface glycoproteins.
1 min
February 2026
Bio Spectrum
Bruker consolidates ownership of TOFWERK in expansion of mass spectrometry portfolio
Bruker Corporation has announced the acquisition of an additional 60 per cent ownership stake in TOFWERK AG, a Switzerland-based innovator in ultra-fast time-of-flight (TOF) mass spectrometry technology for small molecule applied markets, consolidating Bruker's ownership to 100 per cent.
1 min
February 2026
Bio Spectrum
India & Australia develop precision nano-injection platform for breast cancer drug delivery
Researchers from the Indian Institute of Technology Madras (IIT-M), Monash University and Deakin University, Australia, have developed a cutting-edge nano-injection drug delivery platform that has the potential to make breast cancer treatment safer and more effective.
1 min
February 2026
Bio Spectrum
Agilent opens India Refurbishment Centre in Manesar
Agilent Technologies Inc., a global leader in life sciences, diagnostics, and applied chemical markets, has announced the inauguration of its India Refurbishment Centre at its LEED Platinum-certified facility in Manesar, Haryana.
1 min
February 2026
Bio Spectrum
Yashoda Medicity appoints Dr Rajinder Kumar as Unit Head, Department of Neurosurgery
Yashoda Medicity, one of the leading hospitals in the Delhi NCR, has appointed Prof. Dr Rajinder Kumar as Principal Director & Unit Head, Neurosurgery at the Yashoda Institute of Neurosciences.
1 min
February 2026
Translate
Change font size
